Consistent with this theory, Anglesio et al. demonstrated that in endometriosis-associated ovarian carcinoma (EAOC) cases carrying an activating PIK3CA mutation, the same mutation, without differences in allelic frequency, constantly appeared in both cancer and endometriosis specimens, the latter having either typical or atypical histology [56]. This evidence concerns the gene PIK3CA and cancer.